Global Genotyping Kits Market Strategic Research Report

Scope of the Report

The global Genotyping Kits market size is predicted to grow from US$ 1,348 million in 2025 to US$ 2,981 million in 2032; it is expected to grow at a CAGR of 12.2% from 2026 to 2032.

In 2024, the global production of genotyping kits is reach 850,000 units, with an average price of US$1,500 per unit.

Genotyping kits are laboratory tools used to identify genetic variations within DNA sequences. They are designed to detect specific genetic markers, such as single nucleotide polymorphisms (SNPs), insertions/deletions (indels), or larger structural variations, enabling researchers to study genetic traits, mutations, and variations across different samples.

The genotyping kit market is experiencing significant growth and technological change, driven by multiple factors. This growth is primarily driven by the rapid development of precision medicine, the increasing demand for early cancer screening and genetic disease diagnosis, and the continued decline in the cost of genetic sequencing.

North America and Europe remain the world's largest markets, but the Asia-Pacific region, particularly China and India, is becoming the fastest-growing region thanks to its large patient base, government policy support, and domestic technological breakthroughs. Technological advancement is a key driver of industry development. Next-generation sequencing (NGS) currently dominates due to its high throughput and high accuracy. Microarray technology also holds a significant share in clinical screening due to its cost advantages. Future technological development will move towards higher throughput, greater automation, and greater intelligence. The commercial application of cutting-edge technologies such as single-cell typing and nanopore real-time sequencing is accelerating.

On the supply chain side, import customs clearance for genotyping kits involves a series of specialized procedures, including qualification filing, providing documents such as MSDS (Material Safety Data Sheets), Chinese labeling, and compliance with customs regulations for the accurate declaration of product name, quantity, and value. Its manufacturing relies heavily on high-quality raw materials, such as fluorescent probes and enzymes. Currently, the domestic content rate for these raw materials remains below 30%, posing certain supply chain risks. The stability of the global supply chain is susceptible to geopolitical fluctuations and unexpected events, and prices of key raw materials are expected to rise in 2024. Therefore, localized supply chain deployment and stability assurance are gaining increasing importance. The market competition landscape is characterized by a "one superpower, many strong players." The international market is dominated by giants such as Illumina and Thermo Fisher Scientific, while Chinese companies such as BGI, Berry Genomics, and Daan Genomics are rapidly rising through localization strategies and technological innovation. Leading companies are building barriers through "vertical integration + ecological alliances." For example, BGI has connected the multi-omics data platform of 142 tertiary hospitals nationwide, while Berry Genomics has partnered with insurance companies to integrate genetic testing into health insurance products. Meanwhile, many small and medium-sized companies are focusing on specific disease markers or regional services, establishing differentiated advantages in niche markets.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Genotyping Kits market?

What factors are driving Genotyping Kits market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Genotyping Kits market opportunities vary by end market size?

How does Genotyping Kits break out by Type, by Application?

This report presents a comprehensive overview of the global Genotyping Kits market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• PCR-Based Kits
• Next-Generation Sequencing (NGS) Kits
• Microarray-Based Kits

Segment by Application

• Medical Diagnostics
• Biological Research
• Forensic Science
• Drug Development
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Genotyping Kits market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Medical Diagnostics, Biological Research, Forensic Science evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact